⌘K

Login Start Free

Home/Filings/4/0001213900-17-006878

4//SEC Filing

DelMar Pharmaceuticals, Inc. 4

Accession 0001213900-17-006878

$HURACIK 0001498382operating

View on SEC.gov Company Profile

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 11:29 AM ET

Size

4.8 KB

Accession

0001213900-17-006878

Insider Transaction Report

Form 4

Period: 2017-06-26

DelMar Pharmaceuticals, Inc.DMPI

CEO and President10% Owner

Transactions

Purchase
Common Stock
2017-06-26$3.60/sh+6,700$24,120→ 53,345 total

Footnotes (1)

[F1]The Reporting Person purchased the shares in a private transaction for an aggregate purchase price of CDN $32,160. Reported price is based on exchange rate of 0.75.

Documents

1 file

4
f4062617bacha_delmarpharma.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001498382

Filing Metadata

Form type: 4
Filed: Jun 27, 8:00 PM ET
Accepted: Jun 28, 11:29 AM ET
Size: 4.8 KB

View on SEC.gov